- Report
- October 2025
- 500 Pages
Global
From €3492EUR$3,995USD£3,051GBP
- Report
- October 2025
- 300 Pages
Global
From €3492EUR$3,995USD£3,051GBP
- Report
- October 2025
- 250 Pages
Global
From €3492EUR$3,995USD£3,051GBP
- Report
- October 2025
- 300 Pages
Global
From €3492EUR$3,995USD£3,051GBP
- Report
- October 2025
- 200 Pages
Global
From €3492EUR$3,995USD£3,051GBP
- Report
- October 2025
- 300 Pages
Global
From €3492EUR$3,995USD£3,051GBP
- Report
- October 2025
- 500 Pages
Global
From €3492EUR$3,995USD£3,051GBP
- Report
- October 2025
- 500 Pages +
Global
From €3492EUR$3,995USD£3,051GBP
- Report
- December 2025
- 315 Pages
Global
From €4194EUR$4,799USD£3,665GBP
- Report
- January 2026
- 400 Pages
Global
From €5153EUR$6,102USD£4,350GBP
- Report
- February 2026
- 269 Pages
Global
From €5153EUR$6,102USD£4,350GBP
- Report
- February 2026
- 531 Pages
Global
From €5153EUR$6,102USD£4,350GBP
- Report
- January 2026
- 239 Pages
Global
From €5153EUR$6,102USD£4,350GBP
- Report
- December 2025
- 218 Pages
Global
From €4194EUR$4,799USD£3,665GBP
- Report
- December 2025
- 280 Pages
Global
From €4194EUR$4,799USD£3,665GBP
- Report
- December 2025
- 391 Pages
Global
From €4194EUR$4,799USD£3,665GBP
- Report
- September 2025
- 242 Pages
Global
From €2621EUR$2,999USD£2,290GBP
- Report
- May 2025
- 240 Pages
Global
From €4194EUR$4,799USD£3,665GBP
- Report
- September 2025
- 323 Pages
Global
From €5153EUR$6,102USD£4,350GBP
- Report
- March 2025
- 245 Pages
Global
From €5153EUR$6,102USD£4,350GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more